A potential diagnostic pitfall for hobnail variant of papillary thyroid carcinoma.


Journal

Histopathology
ISSN: 1365-2559
Titre abrégé: Histopathology
Pays: England
ID NLM: 7704136

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 13 11 2019
accepted: 04 12 2019
pubmed: 8 12 2019
medline: 27 2 2021
entrez: 8 12 2019
Statut: ppublish

Résumé

Hobnail variant of papillary thyroid carcinoma (PTC) is an aggressive PTC subtype characterised by a hobnail cytomorphology. However, some classic PTC have a 'hobnail-like' cytomorphology associated with thick, hyalinised, variably oedematous fibrovascular cores that appears to be a form of ischaemic/degenerative atypia. We studied three cohorts to compare the histopathological characteristics and clinical outcome of 'hobnail-like' classic PTC and true hobnail variant of PTC: cohort 1, PTC consecutively resected between 2016 and 2017 (to assess frequency of 'hobnail-like' cytomorphology); cohort 2, 20 'hobnail-like' classic PTC resected between 2005 and 2007 (to assess clinical outcome); and cohort 3, seven true hobnail variant of PTC. A 'hobnail-like' cytomorphology was identified in 16% of consecutively resected PTC. Compared with true hobnail variant, 'hobnail-like' classic PTC occurred in younger patients (mean age 40 years versus 68 years, P < 0.001), were smaller tumours (mean tumour size 2.1 cm versus 4.4 cm, P < 0.001), had a lower rate of gross extrathyroidal extension (0% versus 71%, P < 0.001), had a lower proliferative rate (≥3 mitoses per 10 high-power fields seen in 0% versus 71%, P < 0.001; Ki67 index ≥5% in 0% versus 86%, P < 0.001), a lower rate of secondary pathogenic mutations (for cases with molecular data, 0% versus 100%, P = 0.0061) and improved survival (for cases with sufficient clinical outcome data, 10-year disease-free survival of 93% versus 0%, P = 0.0016). Classic PTC can show ischaemic/degenerative atypia that mimics the hobnail cytomorphology of true hobnail variant; however, these tumours lack aggressive histopathological features and pursue an indolent clinical course.

Identifiants

pubmed: 31811787
doi: 10.1111/his.14042
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

707-713

Informations de copyright

© 2020 John Wiley & Sons Ltd.

Références

Asioli S, Erickson LA, Sebo TJ et al. Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am. J. Surg. Pathol. 2010; 34; 44-52.
Asioli S, Erickson LA, Righi A et al. Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum. Pathol. 2013; 44; 320-328.
Amacher AM, Goyal B, Lewis JS et al. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation. Am. J. Surg. Pathol. 2015; 39; 260-265.
Rosai J, Albores Saavedra J, Asioli S et al. Papillary thyroid carcinoma. In Lloyd RV, Osamura RY, Klöppel G, Rosai J eds. World Health Organisation classification of tumours of endocrine organs. Lyon: International Agency for Research on Cancer (IARC), 2017; 81-91.
Saltman B, Singh B, Hedvat CV et al. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression. Surgery 2006; 140; 899-905; discussion p. 6.
Morandi L, Righi A, Maletta F et al. Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma. Endocr. Relat. Cancer 2017; 24; 107-217.
Teng L, Deng W, Lu J et al. Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma. Oncotarget 2017; 8; 22023-22033.
Watutantrige-Fernando S, Vianello F, Barollo S et al. The hobnail variant of papillary thyroid carcinoma: clinical/molecular characteristics of a large monocentric series and comparison with conventional histotypes. Thyroid 2018; 28; 96-103.
Sholl LM, Do K, Shivdasani P et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. JCI Insight 2016; 1; e87062.
Schwock J, Desai G, Devon KM et al. Hobnail-variant of papillary thyroid carcinoma in liquid-based cytology. Diagn. Cytopathol. 2015; 43; 990-992.
Lubitz CC, Economopoulos KP, Pawlak AC et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid 2014; 24; 958-965.

Auteurs

Kristine S Wong (KS)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Tiffany Y Chen (TY)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Sara E Higgins (SE)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Brooke E Howitt (BE)

Department of Pathology, Stanford University Medical Center, Palo Alto, CA, USA.

Jochen H Lorch (JH)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Erik K Alexander (EK)

Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Ellen Marqusee (E)

Division of Endocrinology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Nancy L Cho (NL)

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Matthew A Nehs (MA)

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Gerard M Doherty (GM)

Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Justine A Barletta (JA)

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH